Delhi HC restores ban on 2 diabetes FDCs

The Delhi High Court has made waves with its recent judgment, reinstating a ban on two fixed-dose combination drugs for managing Type II Diabetes Mellitus, significantly affecting leading pharmaceutical corporations. The ruling reaffirmed the government's power to eliminate drugs deemed risky to health.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/aSpsy7h
via IFTTT